Investigating the role of host genetic factors in COVID-19 severity and susceptibility can
inform our understanding of the underlying biological mechanisms that influence adverse …

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a major
public health threat especially in countries with low vaccination rates. To better understand …

Objective The objective is to summarize the knowledge on the epidemiology,
pathophysiology and management of secondary headache attributed to SARS-CoV-2 …

Objectives Vaccination against COVID-19 is highly recommended to patients affected by
multiple sclerosis (MS); however, the impact of MS disease-modifying therapies (DMTs) on …

Three and a half years after the pandemic outbreak, now that WHO has formally declared
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …

The IMPACC cohort, composed of> 1,000 hospitalized COVID-19 participants, contains five
illness trajectory groups (TGs) during acute infection (first 28 days), ranging from milder (TG1 …

Background To summarize modifiable factors for coronavirus disease 2019 (COVID-19)
suggested by Mendelian randomization studies. Methods In this systematic review, we …

Adverse drug reactions (ADRs) rank as one of the top 10 leading causes of death and
illness in developed countries. ADRs show differential features depending upon genotype …

SARS-CoV-2 infection affects different organs and tissues, including the upper and lower
airways, the lung, the gut, the olfactory system and the eye, which may represent one of the …

Abstract The Cooperative Health Research in South Tyrol (CHRIS) is a longitudinal study in
Northern Italy, using dynamic consent since its inception in 2011. The CHRIS study collects …